Literature DB >> 6441887

Myristic acid is attached to the transforming protein of Rous sarcoma virus during or immediately after synthesis and is present in both soluble and membrane-bound forms of the protein.

J E Buss, M P Kamps, B M Sefton.   

Abstract

Myristic acid, a minor component of cellular fatty acids, has been shown previously to be covalently bound to most molecules of p60src, the transforming protein of Rous sarcoma virus. We have now determined at what time during the life cycle of p60src, and where within the cell, this lipid becomes attached to the protein. p60src was found to acquire myristic acid at only one time, during or immediately after its synthesis. p60src is known to be synthesized on free polysomes and appears at the cytoplasmic face of the plasma membrane after a lag of 10 min. The addition of myristic acid to p60src therefore precedes the binding of the protein to the plasma membrane. The lipid attached to p60src is a permanent, metabolically stable part of the protein; we found no evidence for turnover of the myristyl moiety. However, we did find myristate attached to various soluble forms of p60src and to a large number of cytosolic cellular proteins as well. This demonstrates that the attachment of myristic acid to a protein is not in itself sufficient to convert a soluble protein into a membrane-bound protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6441887      PMCID: PMC369279          DOI: 10.1128/mcb.4.12.2697-2704.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Virus-specific messenger RNAs in permissive cells infected by avian sarcoma virus.

Authors:  J S Lee; H E Varmus; J M Bishop
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

2.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

3.  Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose.

Authors:  C B Klee; M H Krinks
Journal:  Biochemistry       Date:  1978-01-10       Impact factor: 3.162

4.  Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo.

Authors:  B M Sefton; K Beemon; T Hunter
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

5.  Temperature-sensitive avian sarcoma viruses: a physiological comparison of twenty mutants.

Authors:  J A Wyke; M Linial
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

6.  The effects of reciprocal changes in temperature on the transformed state of cells infected with a rous sarcoma virus mutant.

Authors:  S Kawai; H Hanafusa
Journal:  Virology       Date:  1971-11       Impact factor: 3.616

7.  TMV coat protein synthesis in vivo: analysis of the N-terminal acetylation.

Authors:  B Filner; A Marcus
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

8.  N-acetyl-seryl-tRNA and polypeptide chain initiation during histone biosynthesis.

Authors:  C C Liew; G W Haslett; V G Allfrey
Journal:  Nature       Date:  1970-05-02       Impact factor: 49.962

9.  Evidence for covalent attachment of fatty acids to Sindbis virus glycoproteins.

Authors:  M F Schmidt; M Bracha; M J Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

10.  Acetylation of nascent polypeptide chains on rat liver polyribosomes in vivo and in vitro.

Authors:  A Pestana; H C Pitot
Journal:  Biochemistry       Date:  1975-04-08       Impact factor: 3.162

View more
  74 in total

1.  Structural role of the matrix protein of type D retroviruses in gag polyprotein stability and capsid assembly.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins.

Authors:  R Prange; A Clemen; R E Streeck
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 3.  Acylation of viral and eukaryotic proteins.

Authors:  R J Grand
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

4.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Demonstration of multiple forms of bovine brain myristoyl CoA:protein N-myristoyl transferase.

Authors:  M J King; R K Sharma
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

6.  Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association.

Authors:  S M Jong; L H Wang
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

7.  Myristoylation is important at multiple stages in poliovirus assembly.

Authors:  N Moscufo; J Simons; M Chow
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation.

Authors:  T A Weaver; A T Panganiban
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Identification, purification and characterization of a membrane-associated N-myristoyltransferase inhibitor protein from bovine brain.

Authors:  M J King; R K Sharma
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

10.  Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line.

Authors:  G Q Daley; R A Van Etten; P K Jackson; A Bernards; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.